Skip to main content
$0.087 -0.003 (-3.33%)

High

$0.09

Low

$0.09

Trades

20

Turnover

$40,231

Volume

455,641
30 June 2023 at 4:10pm
If you were already registered, log in here.

[ARTICLE] Mesoblast shares smashed on Revascor trial

A news article has been posted about Image Resources NL on the AFR. The article was published around , on 15 December 2020 at 11:15am.

Shares in Mesoblast have been smashed at the opening of trade on the ASX on Tuesday tumbling more than 10 per cent after the stem cell therapy group missed its primary endpoint for its pivotal chronic heart failure treatment in trial of Revascor.

Read Article

IMA was $0.190 at the close of trade on 14 December 2020

Find all articles about Image Resources NL, including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.